Danaher Co. (NYSE:DHR – Free Report) – Research analysts at Zacks Research cut their Q2 2025 earnings estimates for shares of Danaher in a note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now forecasts that the conglomerate will post earnings of $1.77 per share for the quarter, down from their prior estimate of $1.85. The consensus estimate for Danaher’s current full-year earnings is $7.67 per share. Zacks Research also issued estimates for Danaher’s Q3 2025 earnings at $1.86 EPS, FY2025 earnings at $7.62 EPS, Q1 2026 earnings at $1.86 EPS, Q2 2026 earnings at $2.05 EPS, Q3 2026 earnings at $2.06 EPS, Q4 2026 earnings at $2.54 EPS, FY2026 earnings at $8.51 EPS and FY2027 earnings at $9.43 EPS.
DHR has been the subject of a number of other research reports. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Royal Bank of Canada restated an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group decreased their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Finally, Citigroup dropped their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $278.00.
Danaher Price Performance
Danaher stock opened at $208.10 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $150.31 billion, a P/E ratio of 39.41, a PEG ratio of 2.61 and a beta of 0.83. The business has a 50-day moving average of $227.21 and a 200-day moving average of $247.52. Danaher has a 1 year low of $196.80 and a 1 year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm earned $2.09 earnings per share.
Danaher Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s payout ratio is currently 20.45%.
Insider Activity
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the fourth quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at about $31,000. Golden State Wealth Management LLC bought a new position in Danaher in the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC grew its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What Does a Stock Split Mean?
- Palantir Stock Skids—How Much Further Can It Fall?
- Profitably Trade Stocks at 52-Week Highs
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- Breakout Stocks: What They Are and How to Identify Them
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.